GLP-1 and Alcohol: Is It Safe to Drink While on Ozempic or Mounjaro. If you're taking a GLP-1 medication like Ozempic (semaglutide) or Mounjaro (tirzepatide), you may have found yourself wondering whether that glass of wine at dinner or a cocktail with friends is still on the table. It's a fair.
If you're taking a GLP-1 medication like Ozempic (semaglutide) or Mounjaro (tirzepatide), you may have found yourself wondering whether that glass of wine at dinner or a cocktail with friends is still on the table. It's a fair question—and an important one.
The short answer is: moderate alcohol consumption may be possible for some people on GLP-1 therapies, but it comes with important caveats. This article breaks down everything you need to know to make an informed decision.
GLP-1 receptor agonists work by mimicking the action of the glucagon-like peptide-1 hormone, which regulates blood sugar, appetite, and digestion. Ozempic and Mounjaro slow gastric emptying—the rate at which your stomach empties its contents into the small intestine. This mechanism is what creates that feeling of fullness that helps you eat less.
Alcohol is also processed through the stomach and liver. When you combine alcohol with a medication that slows digestion, several things can happen:
Log every injection and rotate your sites right in the app.
See it in the appInjection Site Tracker
Rotate injection sites with an interactive body map. Color-coded indicators show your last used and selected sites, linked to your inventory.
Clinical trials for both semaglutide and tirzepatide generally advise caution with alcohol consumption during treatment. While neither medication carries an outright prohibition, the FDA labels and prescribing information for Ozempic note that patients should be aware of the potential for increased sensitivity to alcohol.
A 2023 observational study published in the Journal of Clinical Pharmacology found that patients on GLP-1 therapies who consumed alcohol reported significantly higher rates of adverse events—including nausea, dizziness, and hypoglycemic episodes—compared to those who abstained. The effect was most pronounced in the first 12 weeks of treatment, when doses are being titrated upward.
This is arguably the most serious concern. Alcohol can cause blood sugar to drop, and when combined with a GLP-1 medication that already suppresses appetite and slows digestion, the risk of dangerous hypoglycemia increases—especially if you take insulin or sulfonylureas alongside your GLP-1. Symptoms of hypoglycemia include shakiness, confusion, rapid heartbeat, and sweating. In severe cases, it can lead to loss of consciousness.
Both alcohol and GLP-1 medications independently cause nausea, vomiting, and stomach discomfort. Combined, these effects can be significantly worse. Many patients report that even small amounts of alcohol trigger intense nausea during the early weeks of treatment.
Alcohol is calorie-dense—approximately 7 calories per gram—and provides no nutritional value. For those relying on GLP-1 medications to create a caloric deficit for weight loss, alcohol can quietly sabotage your progress. Additionally, alcohol can lower inhibitions, making it harder to stick to your dietary plan.
Both Ozempic and Mounjaro are metabolized by the liver. Heavy alcohol consumption adds additional liver workload, potentially affecting how your body processes the medication. Patients with existing liver conditions should exercise particular caution.
If you and your healthcare provider decide that occasional moderate drinking is appropriate for your situation, here are some evidence-based recommendations:
The first 12–16 weeks of GLP-1 therapy involve dose escalation. During this period, your body is adjusting to the medication, and side effects are most common. It's generally advisable to avoid alcohol during this phase.
If your doctor approves, limit yourself to:
Always consume alcohol with food. The food in your stomach will help buffer both the medication's effects and alcohol's impact on blood sugar.
Check your blood glucose more frequently when consuming alcohol, especially if you're also on insulin or other diabetes medications. Keep a fast-acting glucose source on hand in case of hypoglycemia.
Alcohol is dehydrating, and so are some GLP-1 side effects like diarrhea and vomiting. Alternate alcoholic drinks with water to stay hydrated.
Avoid sugary mixed drinks and cocktails. Sugary beverages can cause blood sugar spikes and add unnecessary calories. Clear spirits, light beer, or dry wine are generally better choices.
Tirzepatide (Mounjaro) works through dual receptors—GLP-1 and GIP—which may intensify some gastrointestinal effects compared to semaglutide alone. If you're on Mounjaro, be especially conservative with alcohol.
Certain patients should abstain from alcohol entirely while on GLP-1 therapy:
Log every injection and rotate your sites right in the app.
See it in the appEven if you choose to consume alcohol occasionally, stop immediately and seek medical attention if you experience:
The most important step is to have an honest conversation with your healthcare provider about alcohol. They understand your full medical history, current health status, and treatment goals. Together, you can make a decision that balances any potential risks with your quality of life.
Be sure to mention:
There is no one-size-fits-all answer to whether you can safely drink alcohol while on Ozempic or Mounjaro. For some patients, occasional moderate drinking may be acceptable after reaching a stable dose and with proper precautions. For others—especially those with comorbidities, on other diabetes medications, or in the early phases of treatment—avoiding alcohol may be the safer choice.
Your health and safety come first. When in doubt, ask your doctor and err on the side of caution. Learn more about GLP-1 medication safety today.
Disclaimer: This content is informational only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
